.jpg?n=5702 "ByrneWallace Logo")
Advised Dalco Nitrogen systems on the provision of their new nitrogen gas generating system for the production of Bombardier Aerospace’s new CSeries commuter airplanes, resulting in c. £1m in savings per year for Bombardier Aerospace and a greatly reduced environmental footprint.
Date:
Value:
Partners:
Acted for GetItKeepit.com in its recent €400,000 equity capital fundraising, to fund its expansion into Britain and to commercialise its technology as a separate service.
Date:
Value:
Partners:
.jpg?n=7718)
Advised the shareholders of Stokes Bio on the sale of their shareholdings in Stokes Bio Limited as part of a trade sale of the firm to NASDAQ quoted Life Technologies (total sale consideration US$44m).
Date:
Value:
Partners:
Advised Azur on the acquisition of the worldwide rights (other than Europe) to Prialt ® from Elan Pharmaceuticals Inc. which is used for the management of chronic pain in the USA. will offer employment to a 34 person specialty pharmaceutical infrastructure, which is currently supporting the product at Elan.
Date:
Partners:
11/03/2010
Advised the Shionogi Pharmaceuticals Group on a major international licensing agreement with QuatRx, a private pharmaceutical company.
Date:
Partners:
04/03/2010
Advisers to First Derivatives plc in connection with the acquisition of the business and assets of Cognotec Holdings Limited (In Receivership).
Date:
Partners:
23/02/2010
Advisers to Iontas Limited on c.US$15m sale to Verint Systems Inc. (US).
Date:
Value:
Partners:
Advised Atamia on the launch of its new tournament service on their website faceoffgames.com which allows players to gamble on head-to-head matches on their game consoles.
Date:
Partners:
03/02/2010